...
首页> 外文期刊>European review for medical and pharmacological sciences. >CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144
【24h】

CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144

机译:Circrna Ubap2通过海绵MicroRNA-144促进卵巢癌的进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: This study aims to elucidate the regulatory effect of circular RNA UBAP2 (circUBAP2) on the progression of ovarian cancer (OC). PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the expressions of circUBAP2, microRNA-144 and CHD2 in OC tissues and adjacent normal tissues. The correlation between the expression levels of circUBAP2 and microRNA-144 with pathological parameters of OC patients was analyzed. Subcellular distribution of circUBAP2 was detected by chromatin fractionation assay. After overexpression of circUBAP2 in OC cells, changes in proliferative and migratory abilities were evaluated by Cell Counting Kit-8 (CCK-8) and transwell assay, respectively. In addition, the Dual-Luciferase reporter gene assay was used to verify the binding of circUBAP2 and microRNA-144, and the binding of CHD2 to microRNA-144. RESULTS: QRT-PCR results showed that circUBAP2 was highly expressed in OC tissues, and its expression was negatively correlated with TMN stage and five-year survival of OC patients. CircUBAP2 was mainly distributed in the cytoplasm. Overexpression of circUBAP2 significantly promoted the proliferative and migratory abilities of OC cells. The Dual-Luciferase reporter gene assay demonstrated that circUBAP2 could bind to microRNA-144. Meanwhile, circUBAP2 negatively regulated microRNA-144 expression in OC cells. Besides, the promotive effects of circUBAP2 on the proliferation and migration of OC cells were reversed by microRNA-144 overexpression. MicroRNA-144 was lowly expressed in OC tissues, which was negatively correlated with TNM stage of OC patients. The Dual-Luciferase reporter gene assay confirmed the binding condition between CHD2 and microRNA-144. CHD2 expression was negatively regulated by microRNA-144 in OC cells. Moreover, CHD2 could bind to microRNA-144 and partially inhibited its activity, thereby promoting the proliferative and migratory abilities of OC cells. CONCLUSIONS: CircUBAP2 promotes the progression of ovarian cancer by adsorbing microRNA-144.
机译:目的:本研究旨在阐明圆形RNA UBAP2(循环系统2)对卵巢癌进展的调节作用(OC)。患者和方法:使用定量实时 - 聚合酶链式反应(QRT-PCR)检测OC组织和邻近正常组织中循环2,MicroRNA-144和CHD2的表达。分析了对OC患者病理参数的循环2和MicroRNA-144的表达水平之间的相关性。通过染色质分馏测定检测循环分布的亚细胞分布。在OC细胞中过度表达循环2中,通过细胞计数试剂盒-8(CCK-8)和Transwell测定分别评估增殖和迁移能力的变化。此外,双荧光素酶报告基因测定用于验证循环2和microRNA-144的结合,以及CHD2至microRNA-144的结合。结果:QRT-PCR结果表明,循环2在OC组织中高度表达,其表达与TMN阶段和OC患者的五年存活率呈负相关。 Circubap2主要分布在细胞质中。昼夜水平的过度表达显着促进了OC细胞的增殖和迁移能力。双荧光素酶报告总基因测定证明循环2可以与microRNA-144结合。同时,Circubap2在OC细胞中产生负面调节的MicroRNA-144表达。此外,Circubap2对OC细胞增殖和迁移的促进作用被MicroRNA-144过表达反转。 MicroRNA-144在OC组织中较低,与OC患者的TNM阶段负相关。双荧光素酶报告总基因测定证实了CHD2和MICRRNA-144之间的结合条件。 CHD2表达被OC细胞中的microRNA-144负调节。此外,CHD2可以与MicroRNA-144结合并部分抑制其活性,从而促进OC细胞的增殖和迁移能力。结论:Circubap2通过吸附MicroRNA-144来促进卵巢癌的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号